Pharma Major Glenmark Pharmaceuticals Ltd on Tuesday Said It Has Launched a Bioequivalent ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler under the brand name - Tiogiva, in #UK for the treatment of chronic obstructive pulmonary disease .'
Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name - Tiogiva, in #UK for the treatment of chronic obstructive pulmonary disease (COPD). pic.twitter.com/rScutXtPC3— IANS Tweets (@ians_india) June 15, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jun 15, 2021 01:02 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
